Previous Close | 75.72 |
Open | 77.25 |
Bid | 0.00 x 900 |
Ask | 0.00 x 900 |
Day's Range | 74.59 - 78.96 |
52 Week Range | 49.70 - 81.57 |
Volume | |
Avg. Volume | 2,889,233 |
Market Cap | 21.495B |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | 16.21 |
EPS (TTM) | 4.70 |
Earnings Date | Feb 01, 2023 - Feb 06, 2023 |
Forward Dividend & Yield | 1.98 (2.65%) |
Ex-Dividend Date | Sep 30, 2022 |
1y Target Est | 70.92 |
Cardinal Health's (CAH) fiscal second-quarter results benefit from the solid performance of the Pharmaceutical segment.
Lower COVID-19 assays sales and supply chain challenges related to semiconductor chips dent Hologic's (HOLX) top line in Q1.
"I feel good about the balance we have here," CEO Jason Hollar told analysts on a conference call. "I feel very good about the progress to date."